Glaxo Group Ltd
7 products tracked · names used in filings: Glaxo Group Ltd, Glaxo Group Ltd., Glaxo Group Limited
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Bosatria mepolizumab | Application withdrawn | |
| 🇪🇺 | Zunrisa casopitant | Application withdrawn | |
| 🇪🇺 | Trobalt retigabine | Withdrawn | 2011-03-27 |
| 🇪🇺 | Alisade fluticasone furoate | Lapsed | 2008-10-06 |
| 🇪🇺 | Altargo retapamulin | Withdrawn | 2007-05-24 |
| 🇪🇺 | Quixidar fondaparinux sodium | Withdrawn | 2002-03-21 |
| 🇪🇺 | Agenerase amprenavir | Withdrawn | 2000-10-20 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.